TAVT-45

N/A

Report date: 2025/08/29 17:49:12

Base Information

Drug NameTAVT-45
Drug Alias NameAbiraterone acetateTAVT-45
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Steroids
Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitors
TargetsSteroid 17-alpha-hydroxylase
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTavanta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTavanta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A